tm logo
ADRESTIA
Live/Registered
REGISTERED

on 26 Apr 2022

Last Applicant/ Owned by

Lolworth, Cambridge CB23 8DS

GB

Serial Number

79307379 filed on 08th Dec 2020

Registration Number

6709002 registered on 26th Apr 2022

in the Principal Register

Correspondent Address

BEN NATTER

BEN NATTER

745 Fifth Avenue

New York NY 10151

Filing Basis

No Filing Basis

Disclaimer

NO DATA

ADRESTIA

Medical and veterinary preparations for the treatment of immune response disorders, cardiovascular diseases, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases and infectious diseases in humans and animals; pharmaceutical substances and preparations for human use for the diagnosis and treatment of immune r Read More

Classification Information


Class [001]
Chemical Products


Chemicals used in science; biological preparations for use in science; biochemicals for research use; cell lines and bio-production cell lines for scientific, laboratory or medical research; reagents, plasmids and assays for scientific, genetic and medical research; molecular biology research tools, in the nature of biological and biochemical reagents; biological and chemical reagents for research use; chemical reagents for scientific and research purposes; proteins in raw material form for scientific and medical research; gene extracts for research purposes; chemicals and biochemicals for drug discovery, lead identification, diagnostics, profiling and research

Class [005]
Pharmaceutical Products


Medical and veterinary preparations for the treatment of immune response disorders, cardiovascular diseases, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases and infectious diseases in humans and animals; pharmaceutical substances and preparations for human use for the diagnosis and treatment of immune response disorders, cardiovascular diseases, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases and infectious diseases; biopharmaceutical substances and preparations for human use for use in the diagnosis and treatment of immune response disorders, cardiovascular diseases, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases and infectious diseases; reagents, diagnostic preparations and therapeutic preparations in the nature of biological, biochemical and chemical reagents and vaccines for medical purposes; biological preparations for medical purposes, for the diagnosis and treatment of immune response disorders, cardiovascular diseases, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases and infectious diseases; medical preparations for use in gene therapy; diagnostic preparations for medical purposes; therapeutic and diagnostic preparations, namely, small molecules for medical use

Class [042]
Computer & Software Services & Scientific Services


Medical, scientific and industrial research services in the field of cells, cell therapies, genome editing, genetic engineering and gene therapies and targeting therapies to individuals; pharmaceutical and biopharmaceutical research and development services; medical and pharmacological research services; examination and testing of genes for scientific research purposes; development, examination and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; development, examination and testing of medicaments products; development of test systems for pharmaceutical and biopharmaceutical products; development of databases in the medical, pharmaceutical and biopharmaceutical field; development of gene databases; research and development services in the creation of databases and collections of information on biologicals, genetic material, genetic information, chemicals and compounds for research purposes; providing biological and medical research information; providing scientific research information and data in relation to health and disease state; medical research into personalised medicine; medical research services in the field of personalised diagnostics, medical research services in the field of personal medical profiles; provision of scientific research information in the field of personalised medicine; pharmaceutical drug development services; consultancy and advisory relating to all the aforesaid services

Class [044]
Medical, Beauty & Agricultural Services


Medical services; medical and pharmaceutical advisory and consultancy services; preparing pharmaceuticals, namely pharmaceutical compounding services for others; providing personalised medicine services and personalised medical diagnostic reporting services; providing personal medical information; provision of medical information; provision of information to enable human diagnosis of medical conditions; providing medical information to enable healthcare professionals to enable the monitoring of patients; providing medical information to healthcare professionals to enable the assessment of progress in disease and treatment; consultancy and advisory relating to all the aforesaid services

Mark Details


Serial Number

No 79307379

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
26th Apr 2022REGISTERED-PRINCIPAL REGISTER
08th Feb 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08th Feb 2022PUBLISHED FOR OPPOSITION
06th Feb 2022NOTIFICATION PROCESSED BY IB
20th Jan 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
20th Jan 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
20th Jan 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19th Jan 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
19th Jan 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
19th Jan 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED